Rani Therapeutics Ownership | Who Owns Rani Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Rani Therapeutics Ownership Summary

Rani Therapeutics is owned by 65.12% institutional investors, 5.73% insiders, and 29.15% retail investors. Awm investment company is the largest institutional shareholder, holding 17.79% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.80% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rani Therapeutics	65.12%	5.73%	29.15%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Awm investment company	6.50M	17.79%	$8.78M
Vanguard group	5.11M	13.98%	$6.90M
Geode capital management	860.94K	2.36%	$1.16M
Blackrock funding, inc. /de	527.71K	1.44%	$712.41K
Nan fung group	493.58K	1.35%	$246.69K
United services automobile association	302.74K	0.83%	$408.70K
Goldman sachs group	285.83K	0.78%	$385.87K
Kestra private wealth services	254.81K	0.70%	$344.00K
Takeda pharmaceutical	203.19K	0.56%	$101.55K
Ubs group	151.52K	0.41%	$204.56K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Awm investment company	6.50M	0.85%	$8.78M
Takeda pharmaceutical	203.19K	0.62%	$101.55K
Nan fung group	493.58K	0.41%	$246.69K
Lasry marc	62.89K	0.21%	$31.43K
United services automobile association	302.74K	0.03%	$408.70K
Disciplined investors	12.20K	0.01%	$16.47K
Well done	52.01K	0.01%	$70.22K
Act advisors, llc.	16.06K	0.01%	$21.68K
Cwa asset management group	150.00K	0.01%	$202.50K
Lafayette investments	22.98K	0.01%	$31.02K

Top Buyers

Holder	Shares	% Assets	Change
Awm investment company	6.50M	0.85%	6.50M
Vanguard group	5.11M	0.00%	4.22M
Geode capital management	860.94K	0.00%	564.03K
Blackrock funding, inc. /de	527.71K	-	407.48K
Goldman sachs group	285.83K	-	285.83K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-3.15M
Alphabet	-	-	-448.49K
Two sigma investments, lp	-	-	-291.38K
Hrt financial lp	-	-	-113.21K
Two sigma advisers, lp	-	-	-110.16K

New Positions

Holder	Shares	% Assets	Change	Value
Awm investment company	6.50M	0.85%	6.50M	$8.78M
Goldman sachs group	285.83K	-	285.83K	$385.87K
Citigroup	53.09K	-	53.09K	$71.68K
Jefferies financial group	29.87K	0.00%	29.87K	$40.33K
China universal asset management	15.89K	0.00%	15.89K	$21.46K

Sold Out

Holder	Change
Qube research	-3.00
Wells fargo & company/mn	-103.00
Ameritas advisory services	-280.00
Eversource wealth advisors	-980.00
Belvedere trading	-991.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	47	30.56%	23,796,559	490.01%	65	53.46%	35	150.00%	-	-100.00%
Sep 30, 2025	35	-5.41%	4,030,094	-36.17%	11	3.69%	14	40.00%	5	-28.57%
Jun 30, 2025	40	-	6,453,465	89.46%	17	17.02%	10	-23.08%	10	66.67%
Mar 31, 2025	41	-6.82%	3,609,389	-5.48%	10	6.16%	13	-38.10%	6	20.00%
Dec 31, 2024	44	33.33%	3,818,467	-35.40%	13	3.15%	21	61.54%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.70M	3.80%	-
Vanguard Institutional Extnd Mkt Idx Tr	837.97K	0.86%	-
Fidelity Extended Market Index	405.55K	0.42%	204.79K
Tema Obesity & Cardiometabolic ETF	105.60K	0.32%	-
Blackrock Extended Mkt Fund CF	226.79K	0.23%	226.79K
iShares Micro-Cap ETF	195.39K	0.20%	195.39K
Extended Equity Market Fund K	194.52K	0.20%	178.38K
Vifag 2002 SICAV	150.00K	0.15%	150.00K
Fidelity Total Market Index	138.18K	0.14%	70.44K
Bridgeway Ultra-Small Company Market	114.50K	0.12%	114.50K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 23, 2025	IMRAN MIR A		Buy	$1.26M
Oct 23, 2025	IMRAN MIR A		Buy	$1.00M
Oct 20, 2025	South Cone Investments Limited Partnership	-	Sell	$4.64M
Oct 21, 2025	South Cone Investments Limited Partnership	-	Sell	$11.07M
Dec 13, 2024	McKinley Kate	Chief Business Officer	Buy	$29.99K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	2
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	2	2
2024 Q2	-	-

RANI Ownership FAQ

Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 65.12%, followed by 5.73% insiders and 29.15% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 382.13%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Awm investment company (6.5M shares, 17.79%), Vanguard group (5.11M shares, 13.98%), and Geode capital management (860.94K shares, 2.36%). Together, they hold 34.13% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rani Therapeutics.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Awm investment company is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.85% of its assets in 6.5M Rani Therapeutics shares, valued at 8.78M$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 3.80% of its total shares outstanding invested in 3.7M Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools